Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Crexendo, Inc. - Common Stock (NQ:CXDO)

6.120 -0.010 (-0.16%)
Streaming Delayed Price Updated: 12:25 PM EDT, Oct 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Crexendo, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Wednesday. 
Via Benzinga
Topics Stocks
CXDO Stock Earnings: Crexendo Beats EPS, Beats Revenue for Q4 2023
CXDO stock results show that Crexendo beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Recap: Crexendo Q4 Earnings
 
Via Benzinga
Crexendo Announces Fourth Quarter and Fiscal Year 2023 Record Results
Via ACCESSWIRE
Crexendo's Earnings Outlook
 
Via Benzinga
Crexendo Inc. (NASDAQ: CXDO) is a Stock Spotlight on 2/22
Via Investor Brand Network
Crexendo Inc. (NASDAQ: CXDO) is a Stock Spotlight on 2/16
Via Investor Brand Network
Crexendo and TELCLOUD Enter into a Strategic Partnership Agreement
Via ACCESSWIRE
Earnings Scheduled For March 5, 2024
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion. 
Via Benzinga
Crexendo Inc. (NASDAQ: CXDO) is a Stock Spotlight on 2/9
Via Investor Brand Network
Crexendo Inc. (NASDAQ: CXDO) is a Stock Spotlight on 2/8
Via Investor Brand Network
Crexendo Inc. (NASDAQ: CXDO) is a Stock Spotlight on 2/5
Via Investor Brand Network
Crexendo Announces Its 11th Year Providing the Mobile Command Center Communications at the NABC Convention
Via ACCESSWIRE
Crexendo to Present at the 36th Annual Roth Conference March 17-19, 2024, The Ritz Carlton Laguna Niguel in Dana Point, CA
Via ACCESSWIRE
12 Information Technology Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Crexendo, Inc. to Issue Fourth Quarter and Year End 2023 Financial Results on March 5, 2024, at 4:30 PM EST
Via ACCESSWIRE
3 Disruptive Stocks That Could Redefine Their Industries by 2025
Explore three disruptive stocks transforming the travel, healthcare technology, and internet services sectors by 2025. 
Via InvestorPlace
Crexendo Inc. (NASDAQ: CXDO) is a Stock Spotlight on 1/31
Via Investor Brand Network
Crexendo Inc. (NASDAQ: CXDO) is a Stock Spotlight on 1/29
Via Investor Brand Network
Crexendo Inc. (NASDAQ: CXDO) is a Stock Spotlight on 1/25
Via Investor Brand Network
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Crexendo Inc. (NASDAQ: CXDO) is a Stock Spotlight on 1/23
Via Investor Brand Network
Crexendo(R) Breaks Records with Outstanding 36% User Surge in 2023 - Nearly Double the Industry Average, Wins Frost & Sullivan Leadership Award
Via ACCESSWIRE
12 Information Technology Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Crexendo Inc. (NASDAQ: CXDO) is a Stock Spotlight on 1/17
Via Investor Brand Network
Crexendo Continues Rapid Growth, Surpasses Four Million Users
Via ACCESSWIRE
The 3 Best Under-$10 Stocks to Buy in January 2024
These are a few companies for investors looking for inexpensive options that still offer great earnings potential. 
Via InvestorPlace
Crexendo to Present at Needham Growth Conference Presentation On Friday, January 19th at 1:30 ET In Virtual Track 3
Via ACCESSWIRE
12 Information Technology Stocks Moving In Friday's Intraday Session
 
Via Benzinga
12 Information Technology Stocks Moving In Monday's After-Market Session
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.